Skip to main content
Michael Trauner, MD, Dermatology, Ventura, CA

Michael A Trauner MD

Cosmetic Dermatology, Dermatologic Surgery


Premier Dermatology & Mohs Surgery Center

Join to View Full Profile
  • 5855 Olivas Park DrVentura, CA 93003

  • Phone+1 805-667-2801

Dr. Trauner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Michael Trauner is a dermatologist in Ventura, CA. He received his medical degree from Duke University School of Medicine and has been in practice 20 years. He specializes in cosmetic dermatology and dermatologic surgery and is experienced in dermatologic surgery, cosmetic dermatology, and Mohs micrographic surgery.

Education & Training

  • University of California Davis Health
    University of California Davis HealthResidency, Dermatology, 1997 - 2000
  • Kaiser Permanente Northern California (Santa Clara)
    Kaiser Permanente Northern California (Santa Clara)Internship, Internal Medicine, 1994 - 1995
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1995 - 2025
  • Dermatology
    American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Fellow (FAAD) American Academy of Dermatology
  • Fellow (FASDS) American Society for Dermatologic Surgery

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Time to Screen for Liver Disease in Type 2 Diabetes?
    Time to Screen for Liver Disease in Type 2 Diabetes?October 5th, 2020
  • NUDCA Analog Shows Promise in NAFLD
    NUDCA Analog Shows Promise in NAFLDJuly 29th, 2019
  • Gilead Announces Positive Phase 2 Results for GS-9674 in Primary Sclerosing Cholangitis (PSC) at the Liver Meeting
    Gilead Announces Positive Phase 2 Results for GS-9674 in Primary Sclerosing Cholangitis (PSC) at the Liver MeetingNovember 9th, 2018
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: